Insurance companies frequently deny insurance coverage of glucagon-like peptide-1 (GLP-1 ... In this retrospective chart review, researchers followed 599 patients prescribed GLP-1s from July ...

As demand surges for GLP-1 therapies, insurers are pulling back on coverage, according to new data from obesity care provider Found. The company analyzed GLP-1 benefits and access for its patient ...